Login / Signup

Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.

Kelly J HuntMiran A JaffaSara M GarrettDeirdre K LuttrellKenneth E LipsonMaria F Lopes-VirellaLouis M LuttrellAyad A Jaffanull null
Published in: Diabetes care (2018)
Our study indicates that high levels of CTGF/CCN2 predict future MI and cardiovascular death in patients with type 2 diabetes.
Keyphrases
  • growth factor
  • type diabetes
  • cardiovascular disease
  • heart failure
  • clinical trial
  • study protocol
  • left ventricular
  • glycemic control
  • adipose tissue